Quick Answer
Insight Molecular Diagnostics Inc. reported Net Income Loss of -$50.22 million for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +17.2% in Net Income Loss from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$1.37 million | Q2 2015: -$1.41 million | Q3 2015: -$2.42 million | Q1 2016: -$2.93 million | Q2 2016: -$2.54 million | Q3 2016: -$2.60 million | Q1 2017: -$4.70 million | Q2 2017: -$3.80 million | Q3 2017: -$6.91 million | Q1 2018: -$3.78 million | Q2 2018: -$4.51 million | Q3 2018: -$2.97 million | Q1 2019: -$3.86 million | Q2 2019: -$5.38 million | Q3 2019: -$5.23 million | Q1 2020: -$7.73 million | Q2 2020: -$9.11 million | Q3 2020: -$6.78 million | Q4 2020: -$6.31 million | Q1 2021: -$125.0 thousand | Q1 2021: -$3.92 million | Q2 2021: -$10.49 million | Q3 2021: -$13.80 million | Q4 2021: -$35.89 million | Q1 2022: -$10.29 million | Q2 2022: -$8.30 million | Q3 2022: -$9.33 million | Q1 2023: $3.03 million | Q2 2023: -$8.33 million | Q3 2023: -$6.49 million | Q1 2024: -$9.13 million | Q2 2024: -$4.53 million | Q3 2024: -$13.49 million | Q1 2025: -$6.67 million | Q2 2025: -$9.74 million | Q3 2025: -$10.85 million.
- Over the full 12 years of available data (2014 to 2025), Insight Molecular Diagnostics Inc.'s Net Income Loss has declined by 907.3%.
- Historical annual values: Fiscal year 2025: -$50.22 million | Fiscal year 2024: -$60.66 million | Fiscal year 2023: -$27.78 million | Fiscal year 2022: -$72.90 million | Fiscal year 2021: -$64.10 million | Fiscal year 2020: -$29.93 million | Fiscal year 2019: -$22.43 million | Fiscal year 2018: -$15.75 million | Fiscal year 2017: -$19.38 million | Fiscal year 2016: -$11.17 million | Fiscal year 2015: -$8.74 million | Fiscal year 2014: -$4.99 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: